Workflow
星动纪元携旗下核心具身智能产品矩阵亮相WAIC 2025:让通用智能体赋能千行百业
IPO早知道·2025-07-26 12:58

Core Viewpoint - The article highlights the technological advancements and commercial potential of ROBOTERA, a company specializing in embodied intelligence, showcased through its products at WAIC 2025, emphasizing its unique position as the only Tsinghua University-backed enterprise in this field [2][9]. Product Highlights - ROBOTERA's Star L7 humanoid robot demonstrates superior operational control and fine manipulation capabilities, being the first full-size bipedal robot in China to achieve "large movement + fine operation," significantly reducing deployment costs with its multi-form options [4]. - The Star XHAND1 features an industry-first fully direct-driven joint design, boasting 12 degrees of freedom and a maximum grip strength of 80N, capable of lifting 25kg, and can autonomously learn over 1000 complex operations through its collaboration with the ERA-42 model [6][7]. - The Star Q5, designed for service roles, showcases high flexibility and stability, having already been deployed in various retail environments for tasks such as guiding and explaining, thus redefining service robots [6][8]. Technological Integration - The integration of the end-to-end VLA embodied model ERA-42 is crucial, linking hardware performance with scene requirements, facilitating a positive cycle of data collection, model training, and scene implementation, positioning ROBOTERA's products at or above international standards [7]. Commercialization Strategy - The three showcased products have clear commercialization paths: Star L7 targets industrial logistics, Star XHAND1 serves as a core component supplier for research and industrial markets, while Star Q5 focuses on retail and cultural tourism sectors [8]. Market Presence - ROBOTERA has delivered over 200 units, with more than 50% of orders coming from overseas, and has secured clients among 9 of the top 10 global tech companies, validating its vision of empowering various industries with general intelligent agents [9].